Further research is needed to examine the effects of CD44 expression across a wider variety of cancer types and chemotherapy drugs to achieve a more comprehensive understanding of the role of the CD44–HA axis in cancer treatment outcomes, paving the way for chemotherapy management of CD44-positive cancer patients. Here, CD44 is linked to cancer.